c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Pelthos Therapeutics director Matthew Pauls sells $16,506 in shares
Investing.com | Oct 6, 2026 6:16 PM EDT
Read original article